Thryvv : ratio page

Mankind Pharma

Overview Articles News Financials Ratios Shareholding Peers

Financial Ratios

View
Order
Financial Ratios
Mar2024
Mar2023
Mar2022
Mar2021
Mar2020
Valuation Parameters:
PE(x)
48.11
0.00
0.00
0.00
0.00
PCE(x)
39.33
0.00
0.00
0.00
0.00
Price/Book(x)
9.85
0.00
0.00
0.00
0.00
EV/Net Sales(x)
8.81
-0.03
0.06
-0.07
-0.04
EV/Core EBITDA(x)
32.31
-0.12
0.23
-0.23
-0.16
EV/EBIT(x)
37.39
-0.15
0.25
-0.25
-0.17
EV/CE(x)
9.52
-0.03
0.06
-0.07
-0.05
MCap / Sales
8.90
0.00
0.00
0.00
0.00
Growth Ratio:
Net Sales Growth(%)
18.12
12.44
25.22
5.83
17.91
Core EBITDA Growth(%)
38.76
-7.14
20.14
17.54
58.34
EBIT Growth(%)
41.78
-15.60
18.78
17.23
59.00
PAT Growth(%)
48.26
-9.86
12.37
22.43
73.00
EPS Growth(%)
49.23
-10.58
13.28
22.81
78.11
Financial Stability Ratios:
Total Debt/Equity(x)
0.02
0.02
0.14
0.05
0.04
Current Ratio(x)
3.10
2.32
1.68
2.87
2.25
Quick Ratio(x)
2.36
1.52
1.01
2.05
1.54
Interest Cover(x)
69.46
37.52
34.02
80.96
62.87
Operational & Financial Ratios:
Earnings Per Share (Rs)
47.75
32.00
35.78
31.59
25.72
CEPS(Rs)
58.41
40.83
40.43
35.25
28.84
DPS(Rs)
0.00
0.00
0.00
0.00
3.10
Book NAV/Share(Rs)
233.15
185.61
153.65
117.88
87.00
Tax Rate(%)
19.07
21.63
26.42
23.56
26.54
Margin Ratios:
Core EBITDA Margin(%)
23.59
20.89
24.66
25.50
23.68
EBIT Margin(%)
22.64
18.86
25.21
26.49
23.95
Pre Tax Margin(%)
22.32
18.35
24.47
26.16
23.57
PAT Margin (%)
18.06
14.38
18.00
20.00
17.31
Cash Profit Margin (%)
21.76
17.96
20.07
21.84
18.94
Performance Ratios:
ROA(%)
18.01
13.94
18.83
22.79
23.19
ROE(%)
23.15
19.27
26.72
31.51
33.48
ROCE(%)
28.38
23.49
33.96
39.97
43.57
Asset Turnover(x)
1.00
0.97
1.05
1.14
1.34
Sales/Fixed Asset(x)
1.93
1.92
2.52
3.12
3.33
Working Capital/Sales(x)
2.42
3.70
4.53
2.56
3.89
Efficiency Ratios:
Fixed Capital/Sales(x)
0.52
0.52
0.40
0.32
0.30
Receivable days
24.18
19.33
16.25
24.32
22.48
Inventory Days
51.80
65.31
66.57
58.78
51.46
Payable days
120.04
130.57
131.38
144.73
127.01